{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:37:51Z","timestamp":1792424271062,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T00:00:00Z","timestamp":1477008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","jfma-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jfma.2017.01.004","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T14:48:55Z","timestamp":1486997335000},"page":"266-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Early initiation of immunosuppressive treatment in membranous nephropathy patients"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4529-3161","authenticated-orcid":false,"given":"Chieh Kai","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0552-372X","authenticated-orcid":false,"given":"Tai Shuan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Hsiang","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching Fang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen Ling","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Chih","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzong-Shinn","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwan Dun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2017.01.004_bib1","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0270-9295(03)00049-4","article-title":"Diagnosis and natural course of membranous nephropathy","volume":"23","author":"Glassock","year":"2003","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.jfma.2017.01.004_bib2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2215\/CJN.00710805","article-title":"Changing incidence of glomerular disease in Olmsted County, Minnesota: a 30-year renal biopsy study","volume":"1","author":"Swaminathan","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2017.01.004_bib3","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/jcp.39.11.1193","article-title":"Idiopathic membranous glomerulonephritis: aspects of geographical differences","volume":"39","author":"Abe","year":"1986","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jfma.2017.01.004_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0272-6386(12)70160-9","article-title":"Membranous glomerulonephritis and malignancy","volume":"22","author":"Burstein","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jfma.2017.01.004_bib5","first-page":"50","article-title":"Membranous glomerulonephritis and autoimmune thyroid disease","volume":"15","author":"Weetman","year":"1981","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jfma.2017.01.004_bib6","first-page":"121","article-title":"Association of hepatitis B surface (HBs) antigenemia and membranous nephropathy in children in Taiwan","volume":"20","author":"Hsu","year":"1983","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jfma.2017.01.004_bib7","first-page":"28","article-title":"Membranous glomerulonephritis associated with hepatitis B antigen in children: a comparison with idiopathic membranous glomerulonephritis","volume":"23","author":"Yoshikawa","year":"1985","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jfma.2017.01.004_bib8","first-page":"443","article-title":"Membranous nephropathy","volume":"1","author":"Churg","year":"1973","journal-title":"Perspect Nephrol Hypertens"},{"key":"10.1016\/j.jfma.2017.01.004_bib9","first-page":"183","article-title":"Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions","volume":"11","author":"Heymann","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2017.01.004_bib10","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1172\/JCI109248","article-title":"Experimental glomerulonephritis in the isolated perfused rat kidney","volume":"62","author":"Couser","year":"1978","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jfma.2017.01.004_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1681\/ASN.V6135","article-title":"The Heymann nephritis antigenic complex: megalin (gp330) and RAP","volume":"6","author":"Farquhar","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2017.01.004_bib12","first-page":"1074","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"372","author":"Meyer-Schwesinger","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2017.01.004_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2017.01.004_bib14","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"371","author":"Tomas","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2017.01.004_bib15","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1681\/ASN.2012010058","article-title":"Treatment of idiopathic membranous nephropathy","volume":"23","author":"Waldman","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2017.01.004_bib16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.amjmed.2014.07.042","article-title":"Multidisciplinary care program for advanced chronic kidney disease: reduces renal replacement and medical costs","volume":"128","author":"Chen","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.jfma.2017.01.004_bib17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jfma.2014.11.002","article-title":"Membranous nephropathy: a review on the pathogenesis, diagnosis, and treatment","volume":"114","author":"Lai","year":"2015","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2017.01.004_bib18","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/ki.2012.280","article-title":"The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines\u2013application to the individual patient","volume":"82","author":"Radhakrishnan","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2017.01.004_bib19","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1056\/NEJM198404123101503","article-title":"Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy","volume":"310","author":"Ponticelli","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2017.01.004_bib20","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/ki.1995.453","article-title":"A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy","volume":"48","author":"Ponticelli","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2017.01.004_bib21","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1681\/ASN.2009080861","article-title":"Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy","volume":"21","author":"Polanco","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2017.01.004_bib22","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM197912133012401","article-title":"A controlled study of short-term prednisone treatment in adults with membranous nephropathy. Collaborative Study of the Adult Idiopathic Nephrotic Syndrome","volume":"301","author":"Coggins","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2017.01.004_bib23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1056\/NEJM198901263200403","article-title":"A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy","volume":"320","author":"Cattran","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2017.01.004_bib24","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/j.1523-1755.2004.00518.x","article-title":"Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan","volume":"65","author":"Shiiki","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2017.01.004_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ajkd.1998.v31.pm9428445","article-title":"Prognostic factors in idiopathic membranous nephropathy","volume":"31","author":"Reichert","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jfma.2017.01.004_bib26","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1046\/j.1523-1755.1999.07007.x","article-title":"Management of idiopathic membranous nephropathy: evidence-based recommendations","volume":"70","author":"Muirhead","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.jfma.2017.01.004_bib27","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2215\/CJN.04500511","article-title":"Clinical outcomes and predictors for ESRD and mortality in primary GN","volume":"7","author":"Chou","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2017.01.004_bib28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.5414\/CN107681","article-title":"Long-term outcome and prognostic factors of idiopathic membranous nephropathy in the Chinese population","volume":"79","author":"Zuo","year":"2013","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jfma.2017.01.004_bib29","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jfma.2017.01.004_bib30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.ajkd.2013.06.002","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis","volume":"62","author":"Beck","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jfma.2017.01.004_bib31","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/ki.1992.374","article-title":"Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis","volume":"42","author":"Pei","year":"1992","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2017.01.004_bib32","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/ki.1997.127","article-title":"Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications","volume":"51","author":"Cattran","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2017.01.004_bib33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ndt\/gfp390","article-title":"Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial","volume":"25","author":"Hofstra","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jfma.2017.01.004_bib34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM199307083290203","article-title":"Prognosis of untreated patients with idiopathic membranous nephropathy","volume":"329","author":"Schieppati","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2017.01.004_bib35","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/ki.1988.56","article-title":"Idiopathic membranous nephropathy: the natural history of untreated patients","volume":"33","author":"Donadio","year":"1988","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2017.01.004_bib36","first-page":"67","article-title":"Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes","volume":"31","author":"Wehrmann","year":"1989","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jfma.2017.01.004_bib37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM198901053200102","article-title":"A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy","volume":"320","author":"Ponticelli","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2017.01.004_bib38","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1681\/ASN.2013020185","article-title":"Long-term outcomes in idiopathic membranous nephropathy using a restrictive treatment strategy","volume":"25","author":"van den Brand","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2017.01.004_bib39","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1523-1755.2004.00873.x","article-title":"Idiopathic membranous nephropathy: definition and relevance of a partial remission","volume":"66","author":"Troyanov","year":"2004","journal-title":"Kidney Int"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664616303163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664616303163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T02:14:46Z","timestamp":1658628886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664616303163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0929664616303163"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2017.01.004","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early initiation of immunosuppressive treatment in membranous nephropathy patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2017.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017, Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}